Sunshine Biopharma Inc (SBFM)

0.87 +0.01 (+1.35%) USD  |  NASDAQ  |  Apr 30, 11:41
More

Sunshine Biopharma Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for SBFM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Upgrade now.
Date Value
April 25, 2024 --
April 09, 2024 --
November 14, 2023 --
Date Value
August 14, 2023 --
August 07, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

Upgrade
Minimum
Nov 14 2023
Upgrade
Maximum
Apr 09 2024
Upgrade
Average
Upgrade
Median
Aug 07 2023

Revenue Estimates for Next Fiscal Year Benchmarks

Lexaria Bioscience Corp Upgrade
Acasti Pharma Inc Upgrade
Aurinia Pharmaceuticals Inc Upgrade
Edesa Biotech Inc Upgrade
Xenon Pharmaceuticals Inc Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade